Avalon GloboCare Corp. — Investor Relations & Filings

Avalon GloboCare Corp. is a commercial-stage company dedicated to developing and delivering transformative healthcare solutions. The company's activities are centered on two main areas: advancing cell-based immunotherapies and providing precision diagnostics with clinical laboratory services. Its therapeutic development focuses on immune effector cell therapies, including Chimeric Antigen Receptor T-cell (CAR-T) technology. In diagnostics, its core technology platforms include the KetoAir™ breathalyzer, which utilizes nanosensor technology, and the QTY protein design platform, a joint intellectual property with the Massachusetts Institute of Technology (MIT). The company also operates clinical laboratories offering an extensive menu of services, such as general bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics (PGx) testing.